The second neural marker, UCHL-1 (alias PGP9.5), is a unique brain-specific deubiquitinating enzyme upregulated also in neuroblastoma, acute lymphoblastic leukemia, non-small cell lung cancer, and renal cell carcinoma [34,41]. This evidence concerns the gene UCHL1 and renal cell carcinoma.